By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CEL-SCI Corporation 

8229 Boone Boulevard
Suite 802
Vienna  Virginia  22182  U.S.A.
Phone: 703-506-9460 Fax: 703-506-9471


Company News
CEL-SCI (CVM) Is Granted A New European Patent On Its Phase III Investigational Cancer Immunotherapy Multikine 11/17/2015 10:08:43 AM
CEL-SCI (CVM) Announces Closing Of Public Offering For Gross Proceeds Of $11.5 Million 10/28/2015 11:07:25 AM
CEL-SCI (CVM) Prices Public Offering For Up To $12 Million 10/23/2015 10:00:16 AM
CEL-SCI (CVM) Releases Letter To Shareholders 10/19/2015 10:33:39 AM
CEL-SCI (CVM) To Receive Up To $5,000,000 In Litigation Funding To Support Its Arbitration Suit Against Former CRO 10/14/2015 1:17:53 PM
ErgoMed Increases Its Co-Development Contribution Up To $12,000,000 In CEL-SCI (CVM)’s Phase III Head And Neck Cancer Trial 10/5/2015 8:22:49 AM
CEL-SCI (CVM) Reports September Patient Enrollment For Its Phase III Head And Neck Cancer Trial 10/1/2015 10:52:08 AM
CEL-SCI (CVM) Reports August Patient Enrollment For Its Phase 3 Head And Neck Cancer Trial 9/2/2015 11:14:31 AM
CEL-SCI (CVM) Reports Third Quarter Fiscal Year 2015 Financial Results 8/10/2015 9:57:16 AM
CEL-SCI (CVM) Reports Record Monthly Patient Enrollment In July For Its Phase III Head And Neck Cancer Trial 8/3/2015 10:13:20 AM